TITLE

Magnetic microsphere-based methods to study the interaction of teicoplanin with peptides and bacteria

AUTHOR(S)
Piyasena, Menake E.; Real, Lilian J.; Diamond, Rochelle A.; Xu, H. Howard; Gomez, Frank A.
PUB. DATE
November 2008
SOURCE
Analytical & Bioanalytical Chemistry;Nov2008, Vol. 392 Issue 5, p877
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Teicoplanin (teic) from Actinoplanes teichomyceticus is a glycopeptide antibiotic used to treat many Gram-positive bacterial infections. Glycopeptide antibiotics inhibit bacterial growth by binding to carboxy-terminal d-Ala- d-Ala intermediates in the peptidoglycan of the cell wall of Gram-positive bacteria. In this paper we report the derivatization of magnetic microspheres with teic (teic-microspheres). Fluorescence-based techniques have been developed to analyze the binding properties of the microspheres to two d-Ala- d-Ala terminus peptides. The dissociation constant for the binding of carboxyfluorescein-labeled d-Ala- d-Ala- d-Ala to teic on microspheres was established via fluorimetry and flow cytometry and was determined to be 0.5 × 10−6 and 3.0 × 10−6 mol L−1, respectively. The feasibility of utilizing microparticles with fluorescence methods to detect low levels (the limit of bacterial detection was determined to be 30 colon-forming units; cfu) of Gram-positive bacteria has been demonstrated. A simple microfluidic experiment is reported to demonstrate the possibility of developing microsphere-based affinity assays to study peptide–antibiotic interaction.
ACCESSION #
34851677

 

Related Articles

  • Drug Utilization Evaluation of Vancomycin in Teaching Hospitals of Lahore. Liaqat Tarar, Wasam; Farooq, Mehreen; Amin, Fatima; Mahmood, Khawaja Tahir // Journal of Pharmaceutical Sciences & Research;2012, Vol. 4 Issue 2, p1728 

    Vancomycin is the drug of choice in treating severe Gram-positive infections. Drug utilization evaluation is an effective method to promote interventions that will endorse patient outcomes and cost-effectiveness of the drug therapy. The objective of the study undertaken was to observe the...

  • An unusual case of vancomycin-related systemic reaction accompanied with severe thrombocytopenia mimicking pacemaker-related infective endocarditis: a case report and review of literature. Candemir, Basar; Aribuca, Aynur; Koca, Cigdem; Ozcan, Ozgur; Gerede, Menekse; Kaya, Cansin // Journal of Interventional Cardiac Electrophysiology;Nov2013, Vol. 38 Issue 2, p143 

    Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive resistant bacteria. In recent years, several cases of vancomycin-associated immune thrombocytopenia have been presented as case reports, but the real incidence of this side effect...

  • Dalbavancin: A Viewpoint by Eric S. Schweiger. Schweiger, Eric S // Drugs;2008, Vol. 68 Issue 5, p649 

    The author reflects on the therapeutic use and benefits of dalbavancin, a semi-synthetic glycoprotein that works through suppressing bacterial cell wall synthesis and belongs to the class of vancomycin. He believes that using dalbavancin, one can have an additional weapon to fight the lethal...

  • Identification of vancomycin interaction with Enterococcus faecalis within 30 min of interaction time using Raman spectroscopy. Assmann, Cora; Kirchhoff, Johanna; Beleites, Claudia; Hey, Jessica; Kostudis, Sophia; Pfister, Wolfgang; Schlattmann, Peter; Popp, Jürgen; Neugebauer, Ute // Analytical & Bioanalytical Chemistry;Nov2015, Vol. 407 Issue 27, p8343 

    Vancomycin is an important glycopeptide antibiotic which is used to treat serious infections caused by Gram-positive bacteria. However, during the last years, a tremendous rise in vancomycin resistances, especially among Enterococci, was reported, making fast diagnostic methods inevitable. In...

  • Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study. Rodriguez-Pardo, D.; Pigrau, C.; Campany, D.; Diaz-Brito, V.; Morata, L.; Diego, I.; Sorlí, L.; Iftimie, S.; Pérez-Vidal, R.; García-Pardo, G.; Larrainzar-Coghen, T.; Almirante, B. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2016, Vol. 35 Issue 8, p1269 

    Switching from intravenous to oral antibiotic therapy may improve inpatient management and reduce hospital stays and the complications of intravenous treatment. We aimed to assess the effectiveness of intravenous-to-oral antibiotic switch therapy and an early discharge algorithm in hospitalized...

  • Anti-MRSA Cephems: An Update. Springer, Dane M. // Current Medicinal Chemistry - Anti-Infective Agents;Jul2002, Vol. 1 Issue 3, p269 

    A review of recent developments in the field of anti-MRSA cephems is presented. The R.W. Johnson / Microcide collaboration seems to be the most advanced effort to date, but many other companies are continuing their efforts to develop a cephalosporin for use against serious Gram-positive...

  • Introduction. Remington, Jack S. // Clinical Infectious Diseases;9/1/2000 Supplement 3, Vol. 31, pS123 

    Introduces several articles related to the topics discussed at the 'Strategies for the Successful Treatment of Gram-Positive Bacterial Infections' symposium held in September 1999. Panel discussion on the clinical impact of serious gram-positive bacterial infections and strategies to...

  • Strategies for the Successful Treatment of Gram-Positive Bacterial Infection. Remington, Jack S. // Clinical Infectious Diseases;9/1/2000 Supplement 3, Vol. 31, pS150 

    Presents a partial transcription of the panel discussion of the studies presented at 'Strategies for the Successful Treatment of Gram-Positive Bacterial Infections' symposium held in September 1999. Participants in the panel discussion; Multidisciplinary approach to infection control and the...

  • New antibiotic class effectively treats challenging gram-positive infections.  // Formulary;Nov99, Vol. 34 Issue 11, p967 

    Reports on the efficacy of the synthetic antibiotic oxazolidinones in combatting gram-positive organisms that have shown resistance to antibiotics. Clinical trial of linezolid as an alternative treatment for the infections; Cross-resistance between linezolid and other antibiotics; Available...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics